Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SLC25A6P6 is a human pseudogene classified as a non-coding genomic element derived from SLC25A6, which itself is part of the solute carrier family of mitochondrial transporters that mediate the exchange of ADP and ATP across the mitochondrial inner membrane. SLC25A6P6 does not encode a functional protein, and thus has no characterized molecular activity, biological function, disease involvement, or drug interactions. Its relevance is limited to genome annotation, and it is not considered a therapeutic target[2][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6 pseudogene 6 (SLC25A6P6).